FRESENIUS KABI ONCOLOGY LIMITED
OVERVIEW - FRESENIUS KABI ONCOLOGY LIMITED
Fresenius Kabi Oncology Limited is an unlisted public company incorporated on 18 March, 2003. It is classified as a public limited company and is located in New Delhi, Delhi. It's authorized share capital is INR 50.00 cr and the total paid-up capital is INR 48.04 cr.
Fresenius Kabi Oncology Limited's operating revenues range is Over INR 500 cr for the financial year ending on 31 March, 2022. It's EBITDA has increased by 0.58 % over the previous year. At the same time, it's book networth has increased by 2,002.64 %. Other performance and liquidity ratios are available here.
Description: The company manufactures oncology drugs. It produces oral and injectable cancer drugs, etc
Products & Services: oral and injectable cancer drugs, active pharmaceutical ingredients, tablets, capsules, and chemotherapeutic products
Category: Manufacturer
The current status of Fresenius Kabi Oncology Limited is - Active.
The last reported AGM (Annual General Meeting) of Fresenius Kabi Oncology Limited, per our records, was held on 29 August, 2023.
Fresenius Kabi Oncology Limited has five directors - Uday Chandrashekhar Shetty, Nikhil Kulshreshtha, and others.
The Corporate Identification Number (CIN) of Fresenius Kabi Oncology Limited is U24231DL2003PLC119441. The registered office of Fresenius Kabi Oncology Limited is at B- 310, Som Datt Chambers - I, Bhikaji Cama Place, New Delhi, Delhi.
Company360 plans
Know more about your vendors, clients and competitors.
Financials, scores, ratios, excels, reports and more.
@ INR 9000/quarter
Join our newsletter
REGISTERED DETAILS - FRESENIUS KABI ONCOLOGY LIMITED
CIN
U24231DL2003PLC119441
Incorporation Date / Age
18 March, 2003 / 21 yrs
Last Reported AGM Date
29 August, 2023
Authorized Capital
INR 5000.0 Lacs
Paidup Capital
INR 4804.27326 Lacs
industry*
Manufacturing (Chemicals and chemical products)
type
Unlisted Public Company
category
Company limited by Shares
subcategory
Non-govt company
Registered Address
B- 310, Som Datt Chambers - I
Bhikaji Cama Place
New Delhi - 110066
Delhi - India
How to download FRESENIUS KABI ONCOLOGY LIMITED report
A Company report by Tofler is an easy-to-read PDF report that includes company's financial information, ratio analysis, management, group structure, shareholding pattern and more. Such reports can be bought from company pages at Tofler (Sample) or can be downloaded from Company360. Here is the video showing how a report downloaded from Company360 looks like.
FRESENIUS KABI ONCOLOGY LIMITED - Registration Details | ||||||
---|---|---|---|---|---|---|
CIN | U24231DL2003PLC119441 | |||||
Incorporation Date / Age | 18 March, 2003 / 21 yrs | |||||
Last Reported AGM Date | 29 August, 2023 | |||||
Authorized Capital | INR 5000.0 Lacs | |||||
Paidup Capital | INR 4804.27326 Lacs | |||||
industry* | Manufacturing (Chemicals and chemical products) | |||||
type | Unlisted Public Company | |||||
category | Company limited by Shares | |||||
subcategory | Non-govt company | |||||
Email Address | ||||||
Website | ||||||
Registered Address | B- 310, Som Datt Chambers - I Bhikaji Cama Place New Delhi - 110066 Delhi - India |
FINANCIAL HIGHLIGHTS - FRESENIUS KABI ONCOLOGY LIMITED
Operating Revenue | Over INR 500 cr |
EBITDA | 0.58 % |
Networth | 2,002.64 % |
Debt/Equity Ratio | 0.02 |
Return on Equity | 2.89 % |
* Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.
How to get financial reports of FRESENIUS KABI ONCOLOGY LIMITED
Tofler Company360 provides access to any Indian company's financial documents, charts, ratio analysis and more. It lets you compare financials of several companies and study performance trends. These financials can also be downloaded in excel format. Here is the video showing how you can study the financials of an Indian company on the Company360 platform.
Directors - FRESENIUS KABI ONCOLOGY LIMITED
The company has 5 directors and 2 reported key management personnel.
The longest serving director currently on board is Nikhil Kulshreshtha who was appointed on 01 July, 2015. Nikhil Kulshreshtha has been on the board for more than 8 years. The most recently appointed directors are Marc Alexander Mahl and Maximilian Alexander Bohmer, who were appointed on 29 August, 2023.
Uday Chandrashekhar Shetty has the largest number of other directorships with a seat at a total of 1 companies. In total, the company is connected to 0 other companies through its directors.
NAME | DESIGNATION | APPOINTMENT DATE | |
---|---|---|---|
UDAY CHANDRASHEKHAR SHETTY | Director | 25 November, 2020 | No other directorships |
NIKHIL KULSHRESHTHA | KMP | 21 July, 2007 | No other directorships |
NIKHIL KULSHRESHTHA | Director | 01 July, 2015 | No other directorships |
ARVIND KUMAR SHARMA | Director | 01 July, 2018 | No other directorships |
MARC ALEXANDER MAHL | Director | 29 August, 2023 | No other directorships |
MAXIMILIAN ALEXANDER BOHMER | Director | 29 August, 2023 | No other directorships |
Rahul Sharma | KMP | 07 March, 2022 | No other directorships |
NAME | DESIGNATION | APPOINTMENT DATE | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
UDAY CHANDRASHEKHAR SHETTY | Director | 25 November, 2020 | No other directorships | ||||||||||||
|
|||||||||||||||
NIKHIL KULSHRESHTHA | KMP | 21 July, 2007 | No other directorships | ||||||||||||
|
|||||||||||||||
NIKHIL KULSHRESHTHA | Director | 01 July, 2015 | No other directorships | ||||||||||||
|
|||||||||||||||
ARVIND KUMAR SHARMA | Director | 01 July, 2018 | No other directorships | ||||||||||||
|
|||||||||||||||
MARC ALEXANDER MAHL | Director | 29 August, 2023 | No other directorships | ||||||||||||
|
|||||||||||||||
MAXIMILIAN ALEXANDER BOHMER | Director | 29 August, 2023 | No other directorships | ||||||||||||
|
|||||||||||||||
Rahul Sharma | KMP | 07 March, 2022 | No other directorships | ||||||||||||
|
NIKHIL KULSHRESHTHA
KMP
Director
Director
Director
Rahul Sharma
KMP
Director
Director
Previous Names
No previous names were found for this company. |
Previous CINs
L24231DL2003PLC119441 |
SIMILAR COMPANIES
NAME | INCORPORATION YEAR | STATE | PAID UP CAPITAL | |
---|---|---|---|---|
KOPRAN LIMITED
It was formed in year 1958 in Maharashtra . The company currently has a paid up capital of INR 48.21 cr.
|
1958 | Maharashtra | 48.21 cr | Buy financial reports |
ZENARA PHARMA PRIVATE LIMITED
It was formed in year 2004 in Telangana . The company currently has a paid up capital of INR 48.24 cr.
|
2004 | Telangana | 48.24 cr | Buy financial reports |
DHANASHREE AGRO PRODUCTS PRIVATE LIMITED
It was formed in year 1940 in Uttarakhand . The company currently has a paid up capital of INR 48.67 cr.
|
1940 | Uttarakhand | 48.67 cr | Buy financial reports |
MYLAN LABORATORIES LIMITED
It was formed in year 1984 in Telangana . The company currently has a paid up capital of INR 48.70 cr.
|
1984 | Telangana | 48.70 cr | Buy financial reports |
GRAVITI PHARMACEUTICALS PRIVATE LIMITED
It was formed in year 2012 in Telangana . The company currently has a paid up capital of INR 49.00 cr.
|
2012 | Telangana | 49.00 cr | Buy financial reports |
BULI CHEMICALS INDIA PRIVATE LIMITED
It was formed in year 2018 in Maharashtra . The company currently has a paid up capital of INR 46.93 cr.
|
2018 | Maharashtra | 46.93 cr | Buy financial reports |
INOXPA INDIA PRIVATE LIMITED
It was formed in year 2008 in Maharashtra . The company currently has a paid up capital of INR 49.35 cr.
|
2008 | Maharashtra | 49.35 cr | Buy financial reports |
SYMMETRIX BIOTECH PRIVATE LIMITED
It was formed in year 2007 in Maharashtra . The company currently has a paid up capital of INR 49.51 cr.
|
2007 | Maharashtra | 49.51 cr | Buy financial reports |
VVF (INDIA) LIMITED
It was formed in year 2010 in Maharashtra . The company currently has a paid up capital of INR 46.57 cr.
|
2010 | Maharashtra | 46.57 cr | Buy financial reports |
HEUBACH TOYO COLOUR PRIVATE LIMITED
It was formed in year 2013 in Gujarat . The company currently has a paid up capital of INR 49.60 cr.
|
2013 | Gujarat | 49.60 cr | Buy financial reports |
NAME | INCORPORATION YEAR | STATE | PAID UP CAPITAL |
---|---|---|---|
KOPRAN LIMITED | 1958 | Maharashtra | 48.21 cr |
ZENARA PHARMA PRIVATE LIMITED | 2004 | Telangana | 48.24 cr |
DHANASHREE AGRO PRODUCTS PRIVATE LIMITED | 1940 | Uttarakhand | 48.67 cr |
MYLAN LABORATORIES LIMITED | 1984 | Telangana | 48.70 cr |
GRAVITI PHARMACEUTICALS PRIVATE LIMITED | 2012 | Telangana | 49.00 cr |
BULI CHEMICALS INDIA PRIVATE LIMITED | 2018 | Maharashtra | 46.93 cr |
INOXPA INDIA PRIVATE LIMITED | 2008 | Maharashtra | 49.35 cr |
SYMMETRIX BIOTECH PRIVATE LIMITED | 2007 | Maharashtra | 49.51 cr |
VVF (INDIA) LIMITED | 2010 | Maharashtra | 46.57 cr |
HEUBACH TOYO COLOUR PRIVATE LIMITED | 2013 | Gujarat | 49.60 cr |
SUBSIDIARY COMPANIES
No Indian subsidiary companies found.
Company Network - FRESENIUS KABI ONCOLOGY LIMITED
How to use company network of FRESENIUS KABI ONCOLOGY LIMITED
Tofler Company network is a powerful feature that allows you to explore and discover common directorships between companies. It helps you find out other directorships of an Indian director and where else he has business interests. The feature is available for unlimited use in Company360 platform. Here is the video showing how you can explore company networks to discover hidden relationships between companies.
FAQ - FRESENIUS KABI ONCOLOGY LIMITED
-
What is the Incorporation date of FRESENIUS KABI ONCOLOGY LIMITED?
The Incorporation Date of FRESENIUS KABI ONCOLOGY LIMITED is 18 March, 2003.
-
What is the operating revenue of FRESENIUS KABI ONCOLOGY LIMITED?
The operating revenue of FRESENIUS KABI ONCOLOGY LIMITED is in the range of Over INR 500 cr for the financial year ending on 31 March, 2022.
-
What is the change in EBITDA of FRESENIUS KABI ONCOLOGY LIMITED since last year?
The EBITDA of FRESENIUS KABI ONCOLOGY LIMITED has increased by 0.58 % over the previous year. At the same time, it's book networth has increased by 2,002.64 % for the financial year ending 31 March, 2022.
-
What is the business of FRESENIUS KABI ONCOLOGY LIMITED?
The company manufactures oncology drugs. It produces oral and injectable cancer drugs, etc.
-
Which Products and Services are provided by FRESENIUS KABI ONCOLOGY LIMITED?
The products and services offered by FRESENIUS KABI ONCOLOGY LIMITED are oral and injectable cancer drugs, active pharmaceutical ingredients, tablets, capsules, and chemotherapeutic products.
-
Who are the directors of FRESENIUS KABI ONCOLOGY LIMITED?
Fresenius Kabi Oncology Limited has five directors - Uday Chandrashekhar Shetty, Nikhil Kulshreshtha, and others.
Company360 plans
Know more about your vendors, clients and competitors.
Financials, scores, ratios, excels, reports and more.
@ INR 9000/quarter
Join our newsletter
Send e-mail
FRESENIUS KABI ONCOLOGY LIMITED
Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to their respective owners. Read More